Overview

A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether post-operative concurrent chemoradiation with paclitaxel/carboplatin is effective and safe in the treatment of high risk cervical cancer patients.
Phase:
Phase 2
Details
Lead Sponsor:
Korean Gynecologic Oncology Group
Treatments:
Albumin-Bound Paclitaxel
Carboplatin
Paclitaxel